The increasing interest in NAD+ formulations, particularly at higher doses like 1000mg, is being amplified with the emerging profile of Retatrutide – a groundbreaking GLP-1 agonist gaining attention https://gatherbookmarks.com/story23300927/nad-supplement-retatrutide-a-united-kingdom-focus